Gene: TRIM9
Official Full Name: tripartite motif containing 9provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. Its function has not been identified. Alternate splicing of this gene generates two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30807 | TRIM9 Knockout cell line (HCT 116) | Human | TRIM9 | 1:2~1:4 | Negative | Online Inquiry |
KO30808 | TRIM9 Knockout cell line (HEK293) | Human | TRIM9 | 1:3~1:6 | Negative | Online Inquiry |
KO30809 | TRIM9 Knockout cell line (A549) | Human | TRIM9 | 1:3~1:4 | Negative | Online Inquiry |
TRIM9 Gene Knockout Cell Lines are genetically modified cell models specifically designed to facilitate research into the TRIM9 gene, an important player in cellular processes such as protein signaling, immune response, and neurodevelopment. These knockout cell lines offer researchers a valuable tool for examining the roles of TRIM9 and its associated pathways, as they lack the gene's expression, thus providing a clear contrast between normal and altered cellular function.
The primary function of these cell lines is to enable the investigation of TRIM9's involvement in various biological processes, particularly in understanding its influence on neurodegenerative disorders, immune system regulation, and cellular signaling pathways. Researchers can utilize these models to observe the phenotypic consequences of TRIM9 loss, facilitating insights into disease mechanisms and potential therapeutic targets. The knockout technology employed assures a precise and reproducible method for gene disruption, making it easier to conduct functional assays and elucidate TRIM9’s role in cellular biology.
In clinical settings, these cell lines hold great promise for advancing drug discovery and therapeutic interventions. By exploring TRIM9's function, researchers can identify novel drug targets and develop strategies to modulate its activity for therapeutic benefits, particularly in disorders where TRIM9 is implicated, such as autoimmune diseases and various cancers.
Unlike alternative products, TRIM9 Gene Knockout Cell Lines boast the advantage of robust validation and characterization, ensuring high-quality data and experimental consistency. By providing a reliable model for TRIM9-related studies, these cell lines reduce variability and enhance the reproducibility of research findings.
For researchers and clinicians seeking to deepen their understanding of cellular mechanisms and therapeutic approaches, TRIM9 Gene Knockout Cell Lines are an invaluable resource. Their utility in transforming basic research into clinical applications not only supports scientific advancement but also aligns with contemporary needs in therapeutic development. Emphasizing our commitment to high-quality biological products, our company leverages state-of-the-art technologies and expertise to provide innovative tools that empower life science research and accelerate discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.